Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
EditorialEditorial
Open Access

From overtreatment to precision: a new clinical standard for DCIS management

Schlomo Schneebaum
Cancer Biology & Medicine March 2026, 20260010; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0010
Schlomo Schneebaum
Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo 64239, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: schlomos999{at}gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

20260010
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2026.0010

Published By 
Cancer Biology & Medicine
History 
  • Received January 5, 2026
  • Accepted February 25, 2026
  • Published online March 19, 2026.

Copyright & Usage 
Copyright: © 2026, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 23 (4)
Cancer Biology & Medicine
Vol. 23, Issue 4
15 Apr 2026
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
From overtreatment to precision: a new clinical standard for DCIS management
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
From overtreatment to precision: a new clinical standard for DCIS management
Schlomo Schneebaum
Cancer Biology & Medicine Mar 2026, 20260010; DOI: 10.20892/j.issn.2095-3941.2026.0010

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
From overtreatment to precision: a new clinical standard for DCIS management
Schlomo Schneebaum
Cancer Biology & Medicine Mar 2026, 20260010; DOI: 10.20892/j.issn.2095-3941.2026.0010
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • DCIS today: what still holds true
    • Precision medicine arrives
    • Active surveillance: promise with necessary caution
    • Surgical reality: precision without excess
    • Conclusions
    • Conflict of interest statement
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Tumor microenvironment-responsive polymeric nanoparticles for enhanced immunotherapy
  • Cancer nanomedicine for therapy: emerging strategies and expanding perspectives
  • Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies
Show more Editorial

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire